Connect Biopharma Holdings (CNTB) Market Capitalization (2021 - 2026)

Connect Biopharma Holdings has disclosed Market Capitalization across 6 years of filings, most recently posting $149.9 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 175.17% year-over-year to $149.9 million; the TTM figure through Jun 2026 stood at $149.9 million (up 175.17% YoY), while the FY2025 annual figure was $159.2 million, up 108.38% from the prior year.
• Market Capitalization came in at $149.9 million for Q2 2026 at Connect Biopharma Holdings, down from $164.3 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $164.3 million in Q1 2026 to a low of $30.4 million in Q1 2025.
• Average Market Capitalization over 5 years is $85.8 million, with a median of $78.0 million recorded in 2024.
• Year-over-year, Market Capitalization sank 83.12% in 2022 and soared 439.7% in 2026.
• Over 5 years, Market Capitalization stood at $47.9 million in 2022, then surged by 35.78% to $65.0 million in 2023, then gained by 17.47% to $76.4 million in 2024, then soared by 108.38% to $159.2 million in 2025, then decreased by 5.84% to $149.9 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $149.9 million in Q2 2026, $164.3 million in Q1 2026, and $159.2 million in Q4 2025.